Effect of Saibokuto for Post-irradiated Patients with Head and Neck Cancer

Abstract

The therapeutic effect of Saibokuto was studied in 9 patients with several subjective complaints due to irradiation therapy for head and neck cancer.
They were given oral Saibokuto (TJ-96) 7.5 g daily ( 2.5 g three times a day), and the severity of their complaints was investigated before and at least four weeks after the start of treatment.
The medication was effective in all patients and their complaint points were reduced from 12 to 7 as average. No side effects of Saibokuto administration were recognized.
This suggests that Saibokuto is useful to improve the quality of life in p atients with post-irradiated head and neck cancer.